Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
DSM Seeks Partners For Antibiotics
June 25, 2007
| A version of this story appeared in
Volume 85, Issue 26
DSM has completed a strategic review of its anti-infectives business by concluding that it needs partners with operations in low-cost countries. At the same time, the company says it will continue to restructure the business by shifting its production of antibiotic side chains from Spain to China and possibly divesting certain business segments, such as its clavulanic acid operation. It expects to cut 100 jobs in the process. The company says it continues to negotiate a partnership with North China Pharmaceutical for antibiotic production in China.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X